Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Blockade of IL-15 Utilizing Bnz-1, a Selective γ-Chain Inhibiting Peptide, Is Safe and Has Clinical Activity in Patients with T-Cell Large Granular Lymphocytic Leukemia (T-LGLL): Results of a Phase I/II Multi-Center Clinical Trial

Jonathan E. Brammer, MD, Lubomir Sokol, MD PhD, Yutaka Tagaya, MD PhD, Kerry Rogers, Anjali Mishra, PhD, Thomas A. Waldmann, MD, Nazli Azimi, PhD PharmD, Paul Frohna, MD PhD PharmD, Anoshie Ratnayake, MD, Thomas P Loughran, Jr., MD, Karen Ballen, MD

Blood (2019) 134 (Supplement_1): 2835.

https://doi.org/10.1182/blood-2019-129291

Published: 2019

Journal Articles

Phase I Study of Bortezomib Combined with Lenalidomide for Relapsed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Following Hematopoietic Cell Transplantation

Andrew M. Brunner, MD, Traci M. Blonquist, MS, Malgorzata McMasters, MD, Gabriela S. Hobbs, MD, Steven L McAfee, MD, Jacalyn Rosenblatt, MD, Philip C. Amrein, MD, Areej El-Jawahri, MD, Christine Connolly, Aura Ramos, Kaleb Mikami, Emma Logan, Bimalangshu R Dey, MD PhD, Thomas Spitzer, MD, David E. Avigan, MD, Amir T. Fathi, MD MD BS, Yi-Bin Chen, MD, Karen Ballen, MD

Blood (2017) 130 (Supplement 1): 3280.

https://doi.org/10.1182/blood.V130.Suppl_1.3280.3280

Published: 2017

Journal Articles

Assessment of a Multi-Cytokine Profile By a Novel Biochip-Based Assay Reveals Unique Correlation Patterns with Immune Reconstitution after Cord Blood Transplantation in Adults

Theodoros Karantanos, MD, Haesook T Kim, PhD, Lequn Li, MD PhD, Corey Cutler, MD MPH, FRCPC, Joseph H. Antin, MD, Karen Ballen, MD, Jerome Ritz, MD, Ioannis Politikos, MD, Vassiliki A Boussiotis, MD PhD

Blood (2017) 130 (Supplement 1): 1980.

https://doi.org/10.1182/blood.V130.Suppl_1.1980.1980

Published: 2017

Journal Articles

Long Term Follow-up of Recipients of Combined HLA-Matched Nonmyeloablative Bone Marrow and Kidney Transplantation for Multiple Myeloma with End-Stage Renal Disease.

Thomas R Spitzer, MD, Megan Sykes, MD, Nina Tolkoff Rubin, MD, Tatsuo Kawai, MD, Steven L McAfee, MD, Bimalangshu Dey, MD, PhD, Karen Ballen, MD, Francis Delmonico, MD, Susan Saidman, PhD, David H Sachs, M.D., Benedict Cosimi, MD

Blood (2009) 114 (22): 3368.

https://doi.org/10.1182/blood.V114.22.3368.3368

Published: 2009

Journal Articles

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

Corey Cutler, MD, MPH, FRCPC, Rachel Mitrovich, Grace Kao, MD, Vincent Ho, MD, Edwin Alyea, MD, John Koreth, MBBS, Philippe Armand, MD, Bimalangshu Dey, MD, Thomas Spitzer, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Karen Ballen, MD

Blood (2007) 110 (11): 2016.

https://doi.org/10.1182/blood.V110.11.2016.2016

Published: 2007

Journal Articles

The Type of Upfront Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Has No Significant Impact on Clinical Outcomes after Autologous Hematopoietic Stem Cell Transplantation.

Stephen S. Chung, MD, Thomas R. Spitzer, MD, David T. Ting, MD, Christine Dube, Andrew J. Yee, MD, Karen Ballen, MD, Steven L. McAfee, MD, Eyal Attar, MD, Bimalangshu R. Dey, MD, PhD

Blood (2007) 110 (11): 5128.

https://doi.org/10.1182/blood.V110.11.5128.5128

Published: 2007

Journal Articles

Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.

Bimalangshu R. Dey, MD, PhD, Andrew J. Yee, MD, Steven McAfee, MD, Christine Dube, Karen Ballen, MD, Eyal Attar, MD, Christine Colby, Susan Saidman, PhD, Karen Malikowski, Frederic Preffer, PhD, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2007) 110 (11): 5088.

https://doi.org/10.1182/blood.V110.11.5088.5088

Published: 2007

Journal Articles

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Julia Brown, PhD, Karen Ballen, MD, Sean McDonough, Xupeng Ge, MD, PhD, Kristen Stevenson, PhD, Haesook Kim, PhD, Carol Reynolds, Bimalangshu R. Dey, MD, PhD, Steve McAfee, MD, Eyal Attar, MD, Thomas Spitzer, MD, Corey Cutler, MD, Vincent Ho, MD, Edwin Alyea, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2007) 110 (11): 1057.

https://doi.org/10.1182/blood.V110.11.1057.1057

Published: 2007

Journal Articles

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

K. Scott Baker, MD, MS, Anna Hassebroek, MPH, Karen Ballen, MD, Carolyn Bigelow, MD, Haydar Frangoul, MD, Cheryl Hardy, PhD, Stephanie Lee, MD,MPH, Galen Switzer, PhD, J. Douglas Rizzo, MD, John P. Klein, PhD, Navneet Majhail, MD,MS, Stella Davies, MB.BS,PhD

Blood (2007) 110 (11): 3064.

https://doi.org/10.1182/blood.V110.11.3064.3064

Published: 2007

Journal Articles

Cardiac Transplant Followed by High-Dose Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients with AL Amyloidosis and Severe Heart Failure.

Bimalangshu R. Dey, MD, PhD, Thomas R. Spitzer, MD, Thomas E. MacGillivray, MD, Stephen S. Chung, MD, G.W. Dec, MD, David C. Seldin, MD, Steven L. McAfee, MD, Karen Ballen, MD, Eyal Attar, MD, Martha Skinner, MD, Joren C. Madsen, MD, DPhil, Marc J. Semigran, MD

Blood (2007) 110 (11): 732.

https://doi.org/10.1182/blood.V110.11.732.732

Published: 2007

Journal Articles

Effects of Cord Blood Cell Subset Populations in the Development of the Dominant Cord Blood Unit in Non-Myeloablative Sequential Double Cord Blood Transplantation (DCBT).

David T. Ting, MD, Karen Ballen, MD, Thomas R. Spitzer, MD, Richard L. Haspel, MD, Michelle Dorn, Fred Preffer, PhD, Vassiliki Boussiotis, MD PhD, Steven McAfee, MD, Eyal Attar, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Corey Cutler, MD MPH, Vincent Ho, MD, Bimalangshu R. Dey, MD

Blood (2006) 108 (11): 3148.

https://doi.org/10.1182/blood.V108.11.3148.3148

Published: 2006

Journal Articles

In Vivo and Ex Vivo T-Cell Depleted (TCD) NonmyeloablativeHaploidentical Stem Cell Transplantation (NSCT) for Hematologic Malignancy (HM).

Thomas R. Spitzer, MD, Steven L. McAfee, MD, Dey R. Bimalangshu, MD, Karen Ballen, MD, Eyal Attar, MD, Christine Colby, PharmD, Fred Preffer, PhD, Susan Saidman, PhD, Juanita Shaffer, David H. Sachs, MD, Megan Sykes, MD

Blood (2005) 106 (11): 5431.

https://doi.org/10.1182/blood.V106.11.5431.5431

Published: 2005

Journal Articles

Pre-Infusion Characteristics of the Predominant Cord Blood Unit Correlate with Hematopoietic Engraftment in the Setting of Non-Myeloablative Double Cord Blood Transplant (DCBT).

Richard L. Haspel, MD, PhD, Grace S. Kao, MD, Beow Yeap, SC.D, Thomas R. Spitzer, MD, Jerome Ritz, MD, Joseph H. Antin, MD, Karen Ballen, MD

Blood (2005) 106 (11): 3027.

https://doi.org/10.1182/blood.V106.11.3027.3027

Published: 2005

Journal Articles

Outcomes of Patients with Engraftment Syndrome (ES) Following Nonmyeloablative Hematopoietic Stem Cell Transplant (SCT) for Hematologic Malignancy(HM).

Erica Linden, MD, Steven L. McAfee, MD, Bimalangshu R. Dey, MD, Karen Ballen, MD, Susan Saidman, PhD, Christine Colby, PharmD, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2005) 106 (11): 3661.

https://doi.org/10.1182/blood.V106.11.3661.3661

Published: 2005

Journal Articles

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

David T. Ting, MD, Bimalangshu Dey, MD, Ahmed Chaudhary, Christine Colby, Karen Power, Steven McAfee, MD, Karen Ballen, MD, Eyal Attar, MD, Susan Saidman, Frederick Preffer, Robert Sackstein, MD, PhD, Juanita Shaffer, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2005) 106 (11): 3665.

https://doi.org/10.1182/blood.V106.11.3665.3665

Published: 2005

Journal Articles

Outcome of Bone Marrow Transplantation for Myelofibrosis.

Karen Ballen, MD, Kathleen A. Sobocinski, MS, Mei-Jie Zhang, PhD, Mukta Arora, MD, Mary M. Horowitz, MD MS, Sergio Giralt, MD, the Chronic Leukemia Working Committee of the Center for International Blood Marrow Transplant Research

Blood (2005) 106 (11): 170.

https://doi.org/10.1182/blood.V106.11.170.170

Published: 2005

Journal Articles

Favorable Outcomes with Acceptable Toxicity Using a Reduced Intensity Conditioning Regimen for Patients Otherwise Ineligible for Related Donor Allogeneic Stem Cell Transplantation.

Peter Westervelt, MD, PhD, Wendy Holmes, RN, PhD, Robert Emmons, MD, Pamela Becker, MD, PhD, Phil Lowry, MD, Ann Traynor, MD, Karen Ballen, MD

Blood (2004) 104 (11): 5137.

https://doi.org/10.1182/blood.V104.11.5137.5137

Published: 2004

NARROW

Blockade of IL-15 Utilizing Bnz-1, a Selective γ-Chain Inhibiting Peptide, Is Safe and Has Clinical Activity in Patients with T-Cell Large Granular Lymphocytic Leukemia (T-LGLL): Results of a Phase I/II Multi-Center Clinical Trial

Phase I Study of Bortezomib Combined with Lenalidomide for Relapsed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Following Hematopoietic Cell Transplantation

Assessment of a Multi-Cytokine Profile By a Novel Biochip-Based Assay Reveals Unique Correlation Patterns with Immune Reconstitution after Cord Blood Transplantation in Adults

Long Term Follow-up of Recipients of Combined HLA-Matched Nonmyeloablative Bone Marrow and Kidney Transplantation for Multiple Myeloma with End-Stage Renal Disease.

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

The Type of Upfront Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Has No Significant Impact on Clinical Outcomes after Autologous Hematopoietic Stem Cell Transplantation.

Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

Cardiac Transplant Followed by High-Dose Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients with AL Amyloidosis and Severe Heart Failure.

Effects of Cord Blood Cell Subset Populations in the Development of the Dominant Cord Blood Unit in Non-Myeloablative Sequential Double Cord Blood Transplantation (DCBT).

In Vivo and Ex Vivo T-Cell Depleted (TCD) NonmyeloablativeHaploidentical Stem Cell Transplantation (NSCT) for Hematologic Malignancy (HM).

Pre-Infusion Characteristics of the Predominant Cord Blood Unit Correlate with Hematopoietic Engraftment in the Setting of Non-Myeloablative Double Cord Blood Transplant (DCBT).

Outcomes of Patients with Engraftment Syndrome (ES) Following Nonmyeloablative Hematopoietic Stem Cell Transplant (SCT) for Hematologic Malignancy(HM).

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Outcome of Bone Marrow Transplantation for Myelofibrosis.

Favorable Outcomes with Acceptable Toxicity Using a Reduced Intensity Conditioning Regimen for Patients Otherwise Ineligible for Related Donor Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only